BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16538926)

  • 1. Amyloidosis and its impact on patients with ESRD.
    Copeland SD
    Nephrol Nurs J; 2006; 33(1):31-3; quiz 34-5. PubMed ID: 16538926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dialysis amyloidosis and beta-2-microglobulin].
    Sulková S; Votruba T
    Cas Lek Cesk; 1989 Jan; 128(3):68-73. PubMed ID: 2655913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM; Jaber BL
    Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
    Higuchi N; Maruyama H
    Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta 2-microglobulin and amyloidosis: who is at risk?
    Davison AM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of dialysis-related amyloidosis].
    Yamamoto S; Gejyo F; Kazama JJ
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():353-6. PubMed ID: 15250323
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F; Homma N; Arakawa M
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 2-microglobulin amyloidosis: why and how to look for it.
    Schaeffer J; Ehlerding G; Flöge J; Koch KM; Shaldon S
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S3-9. PubMed ID: 8608659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amyloidosis and renal failure].
    Musini S; Savazzi GM
    Recenti Prog Med; 1999 Oct; 90(10):530-5. PubMed ID: 10592739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidosis and its relationship to different dialysers.
    van Ypersele de Strihou C; Floege J; Jadoul M; Koch KM
    Nephrol Dial Transplant; 1994; 9 Suppl 2():156-61. PubMed ID: 8065608
    [No Abstract]   [Full Text] [Related]  

  • 19. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
    Fry AC; Singh DK; Chandna SM; Farrington K
    Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.